Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
Charalampos CharalampousUtkarsh GoelPrashant KapoorMoritz BinderFrancis K BuadiJoselle Madonna CookDavid DingliAngela DispenzieriAmie L FonderMorie A GertzWilson GonsalvesSuzanne R HaymanMiriam A HobbsYi L HwaTaxiarchis V KourelisMartha Q LacyNelson LeungYi LinRahma WarsameRobert A KyleSundararajan Vincent RajkumarShaji K KumarPublished in: Blood cancer journal (2023)